These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
289 related items for PubMed ID: 21630250
21. C5aR and C5L2 act in concert to balance immunometabolism in adipose tissue. Poursharifi P, Lapointe M, Fisette A, Lu H, Roy C, Munkonda MN, Fairlie DP, Cianflone K. Mol Cell Endocrinol; 2014 Jan 25; 382(1):325-333. PubMed ID: 24397921 [Abstract] [Full Text] [Related]
22. Anaphylatoxin C5a-induced toll-like receptor 4 signaling in bovine neutrophils. Stevens MG, Van Poucke M, Peelman LJ, Rainard P, De Spiegeleer B, Rogiers C, Van de Walle GR, Duchateau L, Burvenich C. J Dairy Sci; 2011 Jan 25; 94(1):152-64. PubMed ID: 21183027 [Abstract] [Full Text] [Related]
23. Anaphylatoxin C5a induces inflammation and reduces insulin sensitivity by activating TLR4/NF-kB/PI3K signaling pathway in 3T3-L1 adipocytes. Zhang XY, Liu Y, He T, Yang TT, Wu J, Cianflone K, Lu HL. Biomed Pharmacother; 2018 Jul 25; 103():955-964. PubMed ID: 29710512 [Abstract] [Full Text] [Related]
31. Crosstalk between Toll like receptors and C5a receptor in human monocyte derived DCs suppress inflammatory cytokine production. Zaal A, Lissenberg-Thunnissen SN, van Schijndel G, Wouters D, van Ham SM, ten Brinke A. Immunobiology; 2013 Feb 15; 218(2):175-80. PubMed ID: 22559913 [Abstract] [Full Text] [Related]
32. Complement activation product C5a is a selective suppressor of TLR4-induced, but not TLR3-induced, production of IL-27(p28) from macrophages. Bosmann M, Haggadone MD, Hemmila MR, Zetoune FS, Sarma JV, Ward PA. J Immunol; 2012 May 15; 188(10):5086-93. PubMed ID: 22491257 [Abstract] [Full Text] [Related]
33. Mast cell anaphylatoxin receptor expression can enhance IgE-dependent skin inflammation in mice. Schäfer B, Piliponsky AM, Oka T, Song CH, Gerard NP, Gerard C, Tsai M, Kalesnikoff J, Galli SJ. J Allergy Clin Immunol; 2013 Feb 15; 131(2):541-8.e1-9. PubMed ID: 22728083 [Abstract] [Full Text] [Related]
34. C5a regulates NKT and NK cell functions in sepsis. Fusakio ME, Mohammed JP, Laumonnier Y, Hoebe K, Köhl J, Mattner J. J Immunol; 2011 Dec 01; 187(11):5805-12. PubMed ID: 22058413 [Abstract] [Full Text] [Related]
35. High expression of C5L2 correlates with high proinflammatory cytokine expression in advanced human atherosclerotic plaques. Vijayan S, Asare Y, Grommes J, Soehnlein O, Lutgens E, Shagdarsuren G, Togtokh A, Jacobs MJ, Fischer JW, Bernhagen J, Weber C, Schober A, Shagdarsuren E. Am J Pathol; 2014 Jul 01; 184(7):2123-33. PubMed ID: 24819959 [Abstract] [Full Text] [Related]
36. Sphingosine kinase 1 mediation of expression of the anaphylatoxin receptor C5L2 dampens the inflammatory response to endotoxin. Bachmaier K, Guzman E, Kawamura T, Gao X, Malik AB. PLoS One; 2012 Jul 01; 7(2):e30742. PubMed ID: 22355325 [Abstract] [Full Text] [Related]
37. C5L2 Receptor Represses Brain-Derived Neurotrophic Factor Secretion in Lipoteichoic Acid-Stimulated Pulp Fibroblasts. Chmilewsky F, About I, Chung SH. J Dent Res; 2017 Jan 01; 96(1):92-99. PubMed ID: 28033061 [Abstract] [Full Text] [Related]
38. C5a, but not C5a-des Arg, induces upregulation of heteromer formation between complement C5a receptors C5aR and C5L2. Croker DE, Halai R, Fairlie DP, Cooper MA. Immunol Cell Biol; 2013 Jan 01; 91(10):625-33. PubMed ID: 24060963 [Abstract] [Full Text] [Related]
39. The C5a receptor impairs IL-12-dependent clearance of Porphyromonas gingivalis and is required for induction of periodontal bone loss. Liang S, Krauss JL, Domon H, McIntosh ML, Hosur KB, Qu H, Li F, Tzekou A, Lambris JD, Hajishengallis G. J Immunol; 2011 Jan 15; 186(2):869-77. PubMed ID: 21149611 [Abstract] [Full Text] [Related]
40. C5a/C5aR pathway is essential for up-regulating SphK1 expression through p38-MAPK activation in acute liver failure. Lei YC, Lu CL, Chen L, Ge K, Yang LL, Li W, Wu YH. World J Gastroenterol; 2016 Dec 14; 22(46):10148-10157. PubMed ID: 28028363 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]